Literature DB >> 7043758

Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids.

T E Starzl, T R Hakala, J T Rosenthal, S Iwatsuki, B W Shaw.   

Abstract

The postoperative convalescence period was analyzed for 42 consecutive patients who had cadaveric renal transplantation under therapy with cyclosporin A and steroids. Twenty-two of the patients underwent transplantation for the first time, and the other 20 had retransplantation. None of the recipients has died. With follow-up period of two to eight months, the survival rate of grafts is 96 per cent after first transplantation and 85 per cent after retransplantation. Immunosuppression with a standard regimen was used for all patients at the outset. Early convalescence was highly variable, often necessitating adjustments of cyclosporin A and steroid dosage to accommodate the possibilities of rejection or cyclosporin A nephrotoxicity, or both, simultaneously. Management problems were more frequent and complex in patients undergoing retransplantation. From the results, a classification of convalescence patterns was evolved, with recommendations about how standardized initial therapy should be adjusted if the renal graft does not function promptly or deteriorates later.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043758      PMCID: PMC2729246     

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  15 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts.

Authors:  B D Kahan; C T Van Buren; S N Lin; Y Ono; G Agostino; S J LeGrue; M Boileau; W D Payne; R H Kerman
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939

3.  Liver transplantation, 1980, with particular reference to cyclosporin-A.

Authors:  T E Starzl; S Iwatsuki; G Klintmalm; G P Schröter; R Weil; L J Koep; K A Porter
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Immunological and pharmacological monitoring in the clinical use of cyclosporin A.

Authors:  P A Keown; C R Stiller; R A Ulan; N R Sinclair; W J Wall; G Carruthers; W Howson
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

5.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

6.  100 second renal allografts from a single transplantation institution.

Authors:  N L Ascher; D H Ahrenholz; R L Simmons; J S Najarian
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

7.  Cyclosporin A in cadaveric organ transplantation.

Authors:  R Y Calne; D J White; D B Evans; S Thiru; R G Henderson; D V Hamilton; K Rolles; P McMaster; T J Duffy; B R MacDougall; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

8.  99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.

Authors:  G B Klintmalm; W C Klingensmith; S Iwatsuki; G P Schröter; T E Starzl
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

9.  Sixteen months experience with cyclosporin-A in human kidney transplantation.

Authors:  P Sweny; K Farrington; F Younis; Z Varghese; R A Baillod; O N Fernando; J F Moorhead
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

10.  The use of cyclosporin A and prednisone in cadaver kidney transplantation.

Authors:  T E Starzl; R Weil; S Iwatsuki; G Klintmalm; G P Schröter; L J Koep; Y Iwaki; P I Terasaki; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1980-07
View more
  27 in total

1.  Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine.

Authors:  J T Rosenthal; S Iwatsuki; T E Starzl; R J Taylor; T R Hakala
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

2.  Factors in the Development of Liver Transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal:  Transplant Proc       Date:  1985-10       Impact factor: 1.066

3.  Cadaveric Renal Transplantation With Cyclosporin-A and Steroids.

Authors:  T R Hakala; T E Starzl; J T Rosenthal; B Shaw; S Iwatsuki
Journal:  Transplant Proc       Date:  1983-03       Impact factor: 1.066

4.  The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Authors:  J J Fung; M Eliasziw; S Todo; A Jain; A J Demetris; J P McMichael; T E Starzl; P Meier; A Donner
Journal:  J Am Coll Surg       Date:  1996-08       Impact factor: 6.113

5.  Cadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine.

Authors:  Thomas E Starzl; Thomas B Hakala; J Thomas Rosenthal; Shunzaburo Iwatsuki; Byers W Shaw
Journal:  Diabet Nephrop       Date:  1983-02

6.  Liver transplantation in the ciclosporin era.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel
Journal:  Prog Allergy       Date:  1986

7.  Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants.

Authors:  R D Gordon; S Iwatsuki; B W Shaw; T E Starzl
Journal:  Am J Kidney Dis       Date:  1985-06       Impact factor: 8.860

8.  Cyclosporin A effective therapy for fifty-two cadaver kidney recipients.

Authors:  H Takagi; K Uchida; S Ohshima; T Fujita; T Kano; H Asano; Y Ono
Journal:  Jpn J Surg       Date:  1985-03

9.  Experience with cyclosporine and steroids in clinical renal transplantation.

Authors:  N L Tilney; E L Milford; J L Araujo; T B Strom; C B Carpenter; R L Kirkman
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

10.  Pancreaticoduodenal transplantation in humans.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; D A Greene; D H Van Thiel; M A Nalesnik; J Nusbacher; H Diliz-Pere; T R Hakala
Journal:  Surg Gynecol Obstet       Date:  1984-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.